Skip to main content

Table 1 Comparison of baseline characteristics between the AMI group and the control group

From: The link between different infection forms of Porphyromonas gingivalis and acute myocardial infarction: a cross-sectional study

Indexes

AMI group (n = 382)

Control group (n = 78)

p value

Demographic characteristics

   

Gender [N (%)]

   

 Male

275 (72)

47 (60)

< 0.05

 Female

107 (28)

31 (40)

 

Age [years]

57.51 ± 9.92

61.14 ± 10.19

NS

Medical history [N (%)]

   

 Hypertension

258 (68)

45 (58)

NS

 Diabetes

152 (40)

20 (26)

< 0.05

 CHD [N (%)]

54 (14)

0 (0)

< 0.01

 Current smoking

104 (27)

12 (15)

< 0.05

Previous medication [N (%)]

   

 Aspirin

382 (100)

5 (6)

< 0.01

 Clopidogrel/Ticagrelor

382 (100)

0 (0)

< 0.01

 Statins

375 (98)

15 (19)

< 0.01

 β-blocker

288 (75)

40 (51)

< 0.01

 ACEIs/ARBs

249 (65)

37 (47)

< 0.01

Laboratory indexes

   

 WCC [× 109·L−1]

7.63 ± 2.29

6.49 ± 1.98

< 0.01

 NEUT [× 109·L−1]

5.55 ± 244

4.59 ± 2.09

< 0.01

 Hb [g·L−1]

125.72 ± 14.16

124.31 ± 13.45

NS

 CK [U·L−1]

335.90 ± 432.62

78.32 ± 15.15

< 0.01

 CKMB [U·L−1]

28.58 ± 33.57

10.29 ± 5.87

< 0.01

 Hs-cTnI [ng·mL−1]

13.05 ± 7.31

0.02 ± 0.01

< 0.01

 ALT [U·L−1]

27.20 ± 13.08

26.01 ± 11.23

NS

 AST [U·L−1]

31.13 ± 11.30

28.55 ± 8.04

NS

 TBIL [μmol·L−1]

13.05 ± 3.94

13.82 ± 4.24

NS

 DBIL [μmol·L−1]

3.64 ± 1.99

3.60 ± 2.17

NS

 IBIL [μmol·L−1]

9.41 ± 3.97

9.67 ± 3.84

NS

 TCHO [mmol·L−1]

4.24 ± 0.88

3.93 ± 0.84

< 0.01

 HDL-C [mmol·L−1]

1.09 ± 0.20

1.13 ± 0.18

NS

 LDL-C [mmol·L−1]

2.82 ± 0.73

2.60 ± 0.68

< 0.05

 TRIG [mmol·L−1]

1.41 ± 0.33

1.30 ± 0.38

< 0.05

 Lpa [mg·L−1]

201.31 ± 105.15

177.20 ± 97.08

NS

 CR [μmol·L−1]

80.73 ± 13.73

77.70 ± 13.31

NS

 UA [μmol·L−1]

342.06 ± 87.74

334.49 ± 88.51

NS

 HCY [μmol·L−1]

15.64 ± 9.45

14.67 ± 7.14

NS

Inflammatory indicators

   

 FIB [g·L−1]

3.07 ± 0.60

2.90 ± 0.59

< 0.05

 hsCRP [mg·L−1]

5.06 ± 2.31

4.40 ± 2.64

< 0.05

 ESR [mm·h−1]

7.93 ± 3.57

5.78 ± 3.12

< 0.01

 PCT [ng·mL−1]

0.33 ± 0.17

0.26 ± 0.12

< 0.01

Cardiac ultrasound results

   

 LAD [mm]

37.86 ± 5.50

38.22 ± 4.79

NS

 LVEDD [mm]

48.14 ± 7.63

47.99 ± 6.97

NS

 LVEF [%]

53.36 ± 4.50

57.94 ± 4.42

< 0.01

Pg (+) [N (%)]

   

 Oral cavity

209 (55)

34 (44)

NS

 cfDNA

177 (46)

26 (33)

< 0.05

 gDNA

152 (40)

20 (26)

< 0.05

  1. NS not significant, CHD coronary heart disease, ACEIs/ARBs angiotensin-converting enzyme inhibitors/angiotensin receptor blockers, WCC white cell count, NEUT neutrophil count, Hb hemoglobin, CK creatine kinase, CKMB myocardial bound creatine kinase, hs-cTnI hypersensitive cardiac troponin I, ALT alanine transferase, AST aspartate aminotransferase, TBIL total bilirubin, DBIL direct bilirubin, IBIL indirect bilirubin, TCHO total cholesterol, HDL-C high-density lipoprotein cholesterol, LDL-C low-density lipoprotein cholesterol, TRIG triglyceride, Lpa lipoprotein a, CR creatinine, UA uric acid, HCY homocysteine, FIB fibrinogen, hsCRP high sensitivity C-reactive protein, ESR erythrocyte sedimentation rate, PCT procalcitonin, LAD left atrial diameter, LVEDD left ventricular end-diastolic dimension, LVEF left ventricular ejection fraction, Pg Porphyromonas gingivalis, cfDNA circulating free DNA, gDNA genomic DNA